搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Drosophila melanogaster Putative odorant receptor 13a (Or13a), partial CSB-YP895210DLU1
CSB-EP895210DLU1
CSB-BP895210DLU1
CSB-MP895210DLU1
CSB-EP895210DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster DnaJ homolog subfamily C member 25 homolog (CG7872), partial CSB-YP895211DLU1
CSB-EP895211DLU1
CSB-BP895211DLU1
CSB-MP895211DLU1
CSB-EP895211DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster MAP kinase-activating death domain protein (rab3-GEF), partial CSB-YP895212DLU
CSB-EP895212DLU
CSB-BP895212DLU
CSB-MP895212DLU
CSB-EP895212DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Selenoprotein BthD (BthD), partial CSB-YP895213DLU
CSB-EP895213DLU
CSB-BP895213DLU
CSB-MP895213DLU
CSB-EP895213DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Poly (A) RNA polymerase gld-2 homolog B (wisp), partial CSB-YP895214DLU
CSB-EP895214DLU
CSB-BP895214DLU
CSB-MP895214DLU
CSB-EP895214DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Peptidoglycan-recognition protein SA (PGRP-SA) CSB-YP895215DLU
CSB-EP895215DLU
CSB-BP895215DLU
CSB-MP895215DLU
CSB-EP895215DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Probable 6-phosphogluconolactonase (CG17333) CSB-YP895216DLU
CSB-EP895216DLU
CSB-BP895216DLU
CSB-MP895216DLU
CSB-EP895216DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster F-box/WD repeat-containing protein 7 (ago), partial CSB-YP895217DLU
CSB-EP895217DLU
CSB-BP895217DLU
CSB-MP895217DLU
CSB-EP895217DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Protein translation factor SUI1 homolog (CG17737) CSB-YP895218DLU
CSB-EP895218DLU
CSB-BP895218DLU
CSB-MP895218DLU
CSB-EP895218DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Peroxidasin (Pxn), partial CSB-YP895219DLU
CSB-EP895219DLU
CSB-BP895219DLU
CSB-MP895219DLU
CSB-EP895219DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Probable chitinase 2 (Cht2) CSB-YP895220DLU
CSB-EP895220DLU
CSB-BP895220DLU
CSB-MP895220DLU
CSB-EP895220DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Putative gustatory receptor 61a (Gr61a), partial CSB-YP895221DLU1
CSB-EP895221DLU1
CSB-BP895221DLU1
CSB-MP895221DLU1
CSB-EP895221DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Mitochondrial import inner membrane translocase subunit TIM50-B (ttm2), partial CSB-YP895222DLU1
CSB-EP895222DLU1
CSB-BP895222DLU1
CSB-MP895222DLU1
CSB-EP895222DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Troponin C-akin-1 protein (Tina-1) CSB-YP895223DLU
CSB-EP895223DLU
CSB-BP895223DLU
CSB-MP895223DLU
CSB-EP895223DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Probable tyrosine--tRNA ligase, mitochondrial (CG16912), partial CSB-YP895224DLU
CSB-EP895224DLU
CSB-BP895224DLU
CSB-MP895224DLU
CSB-EP895224DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster N-alpha-acetyltransferase, 35 NatC auxiliary subunit homolog (CG4065), partial CSB-YP895225DLU
CSB-EP895225DLU
CSB-BP895225DLU
CSB-MP895225DLU
CSB-EP895225DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Benign gonial cell neoplasm protein (bgcn), partial CSB-YP895226DLU
CSB-EP895226DLU
CSB-BP895226DLU
CSB-MP895226DLU
CSB-EP895226DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Putative gustatory receptor 59e (Gr59e), partial CSB-YP895227DLU1
CSB-EP895227DLU1
CSB-BP895227DLU1
CSB-MP895227DLU1
CSB-EP895227DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Putative gustatory receptor 59c (Gr59c), partial CSB-YP895228DLU1
CSB-EP895228DLU1
CSB-BP895228DLU1
CSB-MP895228DLU1
CSB-EP895228DLU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster PRADC1-like protein (CG9849) CSB-YP895229DLU
CSB-EP895229DLU
CSB-BP895229DLU
CSB-MP895229DLU
CSB-EP895229DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>